Abstract

Ten non-diabetic psychiatric patients, who had not previously been treated with insulin, underwent insulin coma therapy by recrystallized, non-monocomponent human insulin in neutral solution. The treatment was given for 1–3 months, in maximum doses of 96–196 units daily. Several patients formed insulin antibodies. The cause of the antibody formation is discussed. The presence of small quantities of the a-fraction in the insulin is assumed to be of importance in the insulin antibody formation.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call